San Diego, CA, United States of America

Michael Hodges

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Basilea Pharmaceutica International Ag, Allschwil. Active years: 2026.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Michael Hodges: Innovator in Antifungal Treatments

Introduction

Michael Hodges is a notable inventor based in San Diego, California. He has made significant contributions to the field of medicine, particularly in the treatment of fungal infections. His innovative approach has led to the development of a unique antifungal agent.

Latest Patents

Hodges holds a patent for the "Use of compounds in the treatment of fungal infections." This patent describes the use of compound 1, an antifungal agent with a novel mechanism of action, in the treatment of fungal infections. His work in this area is crucial for advancing medical treatments and improving patient outcomes.

Career Highlights

Michael Hodges is associated with Basilea Pharmaceutica International AG, a company known for its focus on innovative medicines. His role in the company has allowed him to contribute to groundbreaking research and development in antifungal therapies.

Collaborations

Hodges collaborates with Karen Joy Shaw, a fellow professional in the field. Their partnership exemplifies the importance of teamwork in driving innovation and achieving successful outcomes in research.

Conclusion

Michael Hodges is a dedicated inventor whose work in antifungal treatments is paving the way for new medical advancements. His contributions are vital to the ongoing fight against fungal infections, showcasing the impact of innovation in healthcare.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…